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ABSTRACT
One of the most common regulatory elements is the
GC box and the related GT/CACC box, which are
widely distributed in promoters, enhancers and locus
control regions of housekeeping as well as tissue-
specific genes. For long it was generally thought that
Sp1 is the major factor acting through these motifs.
Recent discoveries have shown that Sp1 is only one
of many transcription factors binding and acting
through these elements. Sp1 simply represents the
first identified and cloned protein of a family of tran-
scription factors characterised by a highly conserved
DNA-binding domain consisting of three zinc fingers.
Currently this new family of transcription factors has
at least 16 different mammalian members. Here, we
will summarise and discuss recent advances that have
been directed towards understanding the biological
role of these proteins.
INTRODUCTION
G-rich elements such as GC (GGGGCGGGG) and GT/CACC
boxes (GGTGTGGGG) are important cis-acting elements
required for the appropriate expression of housekeeping as
well as many tissue-specific and viral genes. These motifs have
been found and functionally analysed in promoters, enhancers
and locus control regions (LCRs) of genes that are under
different modes of control, such as cell cycle regulation,
hormonal activation and developmental patterning. Moreover,
GC/GT boxes are commonly found in promoters embedded in
CpG-rich methylation-free islands. Maintenance of the appro-
priate methylation patterns is essential for normal development
(1). It has been shown for the APRT gene that the GC/GT
motifs are required to maintain the methylation-free active status
of the gene (2,3).
For long it has been known that the general transcription
factor Sp1 (named according to the original purification
scheme that included Sephacryl and phosphocellulose columns)
(4) can bind and act throughGC/GT boxes, and Sp1 was therefore
thought to be an extremely versatile protein essential for many
different functions of the mammalian nucleus. More recently,
however, it has become clear that Sp1 is not the only transcription
factor binding and acting through these elements. It simply
represents the first identified and cloned protein of a new and
still growing family of transcription factors. Family members
contain a highly conserved DNA-binding domain consisting of
three zinc fingers. Currently this family of transcription factors
comprises at least 16 different mammalian members (Fig. 1).
Accordingly, our view on Sp1 recognition elements as well as
Sp1 itself has changed dramatically. The identification of all
these transcription factors binding to Sp1 sites raises the question
that is central to this review: what are the functions of these
proteins?
THE ZINC FINGER REGION DEFINES THE FAMILY
The 81 amino acid DNA-binding domain that is found close to
the C-termini of all members essentially defines the Sp/XKLF
family of transcription factors. It consists of three C2H2-type
zinc fingers arranged similar to those found in the Drosophila
melanogaster regulator protein Krüppel. Accordingly, some of
the proteins have been named Krüppel-like factors. The striking
similarity of the linker amino acids between the individual
fingers as well as the identical length of the DNA-binding
domain strongly suggest that the higher order structure of the
three fingers is crucial for the biological function of the pro-
teins (Fig. 2). Structural studies on zinc finger peptides bound
to DNA have provided information that allows predictions on
the DNA sequence recognised by finger domains. The amino
acids of the Sp1 zinc fingers that are most likely to make specific
contacts with the DNA are the amino acids KHA within the
first, RER within the second and RHK within the third zinc
finger domain (Fig. 2). These critical amino acids are conserved
in Sp3, Sp4, BTEB1, TIEG1 and TIEG2 proteins (Fig. 2). Con-
sistent with this conservation, Sp3, Sp4, BTEB1 and TIEG2
recognise classical Sp1-binding sites (5–7). In addition, the
relative affinity for the GC box is very similar, if not identical,
between these proteins (5,6). GT or CACCC boxes are also
recognised by these proteins but with slightly lower affinities
(5). In Sp2, a leucine residue replaces the critical histidine residue
within the first zinc finger (Fig. 2). Although not studied in
detail, it was shown that Sp2 does not bind to the classical Sp1
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In all the other family members, the DNA-contacting amino
acids of the first and second fingers are conserved. In the third
finger, however, the critical lysine is replaced in some
members by a leucine (Fig. 2). Thus, one would expect slight
differences in the DNA-binding site preferences of the
members of this subfamily. In agreement with this structural
determinant it was shown that EKLF, UKLF and BKLF have a
binding preference for GT boxes over classical GC boxes (9–12).
NOMENCLATURE AND CLASSIFICATION
Based on the structural relationships between the proteins
(Figs 1 and 2), we suggest dividing the Sp/XKLF family into
three subgroups: (i) the four Sp transcription factors; (ii) the
close relatives, which currently consist of BTEB1, TIEG1 and
TIEG2; (iii) the Krüppel-like factors (XKLFs). The latter sub-
family also includes BTEB2, GBF/ZF9, ZNF741 and AP-2rep.
Features of individual family members are summarised in
Table 1.
To date, four Sp genes have been identified in the mammalian
genome. The overall domain structure of these factors is very
similar (Fig. 3). In addition to the highly conserved C-terminal
zinc finger region, they contain glutamine-rich activation
domains flanked by serine/threonine-rich stretches. Their evo-
lutionary relationship is well documented by the co-localisation of
the four human Sp genes with the four HOX gene clusters on
chromosomes 12q13 (Sp1/HOX C) (13), 17q21.3–q22 (Sp2/
HOX B) (14), 2q31 (Sp3/HOX D) (15) and 7p15 (Sp4/HOX
A) (16). Sp1, Sp3 and Sp4 are more closely related to each
other than to Sp2. This is especially evident on comparison of
the three zinc fingers, which reveal significant differences
between Sp2 and the other three factors (Fig. 2).
As outlined above, in BTEB1, TIEG1 and TIEG2 all amino
acids that are believed to specifically contact the DNA are con-
served and these proteins consistently recognise the classical
GC box. However, the domains N-terminal to the zinc fingers
do not share any similarity to the Sp factors. BTEB1, originally
named simply BTEB (basic transcription element binding
protein), has been identified and cloned along with rat Sp1 by
virtue of its binding to the basal transcriptional element (GA-
GAAGGAGGCGTGGCCAAC) of the cytochrome P-4501A1
Figure 1. Phylogenetic tree of the Sp/XKLF transcription factors. The tree was
generated with the CLUSTALWMultiple Sequence Alignment Program v.1.7
(June 1997) (90) using the amino acid sequences of the DNA-binding domains
of the Sp/XKLF proteins.
Figure 2. Protein sequence alignment of the zinc finger domains of mammalian Sp/XKLF family members. All sequences are human sequences with the exception
of LKLF, AP-2rep, BKLF and IKLF, which are of mouse origin. The cysteine and histidine residues that are involved in zinc coordination are in blue. Arrows point
to the amino acid positions that probably determine the recognition specificity of the fingers by contacting specific bases of the DNA. Black lines indicate α-
helices; β-sheets are shown as zig-zag lines. The amino acids that are thought to make base contacts are boxed (adapted from 69). Residues conserved between all
family members are indicated (*).
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also been cloned from mouse (18) and man (19). Human
TIEG1 (TGFβ-inducible early gene), also named EGRα (early
growth response gene α), has been cloned independently by
differential display PCR from a human fetal osteoblast cell line
after TGFβ treatment (TIEG1; 20) and an androgen-dependent
prostate cell line (EGRα; 21). Both proteins are expressed
from alternative promoters of the same gene. TIEG1 differs
from EGRα by the presence of 11 additional amino acids at its
N-terminus (22). The mouse orthologue of human TIEG1 has
been termed mGIF (mouse glial cell-derived neurotrophic fac-
tor inducible factor) (23). The recently cloned human TIEG2
protein (7) is distinct from TIEG1/EGRα/mGIF, although
structurally and functionally closely related to TIEG1. The 512
amino acid protein contains several proline-rich regions and
shares 44% similarity to TIEG1 outside the DNA-binding
domain (Fig. 3) (7). The expression of TIEG proteins is up-
regulated in response to TGFβ, by the glial cell-derived neuro-
trophic factor (GDNF) (23), a distant member of the TGFβ
family of proteins, and by other hormones like EGF and
oestrogens (24,25).
The third group of proteins have been dubbed XKLFs
(pronounce X-klefs) or ‘Krüppel-like factors’ after theD.melano-
gaster zinc finger protein Krüppel. The ‘X’ usually indicates
the major expression site of the factor, i.e. erythroid cells
(EKLF) (12,26), gut (GKLF) (27), also called epithelial zinc
finger protein (EZF) (28), intestine (IKLF) (29), lung (LKLF)
(30), ubiquitous (UKLF) (10) or fetal (FKLF) (31). However,
these names are somewhat misleading because expression is
not always restricted to these tissues. Another ubiquitously
expressed factor has been named basic (BKLF) because its N-
terminus is rich in basic residues (9). BKLF is probably identical
to TEF-2, a protein that binds to the GT-I motif of the SV40
enhancer (32). Furthermore, four additional members of this
subfamily have been reported, including basic transcription
element binding protein 2 (BTEB2) (33), zinc finger protein
741 (ZNF741) (only sequence in database), repressor of AP-2
transcription (AP-2rep) (18) and zinc finger protein 9 (Zf9)
(34). The latter is also known as core promoter binding protein
(CPBP) (35) and GC-rich binding factor (GBF) (36).
Zf9/CPBP/GBF is distinct from but closely related to UKLF
(10). Similarities are not only seen in the C-terminal zinc finger
region but also in the N-terminal part of the protein. Most
significantly, the first N-terminal 47 amino acids of UKLF and
Zf9/CPBP/GBF are highly conserved (Fig. 3). This conserved
domain is rich in acidic amino acids and lies within the trans-
activation domain of the proteins (10).
BTEB2 has been originally cloned from a human placenta
cDNA library using rat BTEB1 as a probe (33). However,
BTEB2 ismore related to theKrüppel-like factors than to BTEB1.
BTEB2 is probably an N-terminal truncated human orthologue of
murine IKLF, since the designated 5'-untranslated region of
human BTEB2 is highly conserved within the coding region of
IKLF. It remains to be clarified whether the published BTEB2
cDNA sequence is incomplete or might contain mutations in
the assigned 5'-untranslated region that would lead to an N-
terminal truncated protein.
Table 1. Classification and function of Sp/XKLF proteins
Species: H, human; M, mouse; R, rat; S, pig; X, Xenopus.
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The majority of the Sp/XKLF transcription factors have been
reported to act in a positive manner. Some factors, however,
exert an inhibitory effect on transcription. Sp3 was originally
found to repress Sp1-mediated activation by binding to the
same site and thereby preventing Sp1 binding and activation
(37). Similarly, BTEB1 activated the AP2 promoter while AP-2rep
repressed it by competing for the same site (18). In addition,
BKLF has been shown to compete with EKLF thereby silencing
EKLF-mediated activation (38). These examples suggest
mechanisms by which the expression of target genes might be
regulated by competition between repressors and activators.
However, the attractive simplicity of such models is already
challenged by the observation that repressors can also function
as activators, as has been demonstrated for Sp3 and BKLF
(9,39,40). In addition, TIEG1/EGRα was reported to be an
activator (24), yet in other experiments it acted as a repressor
(7,23). The features determining whether these proteins act as
repressors or activators are not well understood. In the case of
Sp3 and BTEB1, the structure and the arrangement of the
recognition sites appear to determine the effect on transcription.
Promoters containing a single binding site are activated,
whereas promoters with multiple binding sites often do not or
only weakly respond to Sp3 (40). Vice versa, BTEB1 activated
promoter constructs with multiple GC boxes but repressed
transcription of constructs containing a single GC box (17).
Whether Sp3 acts as an activator or as a repressor of Sp1-mediated
activation might also depend on the cellular context (41).
Discrepant reports on activation/repression functions are
likely due to the use of different experimental systems and con-
ditions, but might also reflect the modular structure of these
transcription factors. Both activation and repression domains
have been identified in Sp1 (42), Sp3 (40), EKLF (43) and
GKLF/EZF (28). Themolecular basis for the inhibitory activity of
Sp3 has been mapped to a transferable repression domain
located between the second glutamine-rich activation domain
and the first zinc finger function (Fig. 3) (40). The amino acid
triplet KEE within this domain is absolutely essential for
repressor function (40). Unraveling the transcriptional role of
Sp3 is further complicated by the fact that three Sp3 isoforms
exist. The full-length 115 kDa Sp3 is initiated at a non-AUG
codon (8) whereas two smaller ~70 kDa Sp3 species arise from
internal translation initiation sites (44). All three isoforms
contain the inhibitory domain. The full-length Sp3 carries both
glutamine-rich activation domains whereas the smaller species
contain only the second activation domain B and thus can act
only as very weak activators. So far, it is not known whether
the relative abundance of the different Sp3 isoforms varies
under certain conditions. We can only assume that such modular
structures would allow regulation of the transcriptional activity
of these factors.
PHYSIOLOGICAL FUNCTION OF Sp/XKLF PROTEINS
Although it is satisfactory that there are at least 16 different
proteins that can serve as effectors of the large variety of
biological functions that have been assigned to Sp1 binding
sites, the downside is that it raises the question which tasks are
performed by which family members in vivo? This question is
particularly complicated because different factors are often
present in the same cells and hence the prospect of overlapping
functions is always looming. Gene inactivation in mice has
been the most powerful tool to elucidate specific functions of
individual family members. Knockouts of Sp1, Sp4, EKLF,
LKLF and BKLF have been described, all of them resulting in
surprisingly different phenotypes. This is consistent with the
idea that the number of zinc finger genes has increased during
evolution to fulfil the requirement for specialised functions in
multicellular organisms.
Sp1: a complex puzzle with few easy pieces
The ubiquitously expressed Sp1 protein has been implicated in
the activation of a very large number of genes and is thought to
be involved in cellular processes such as cell cycle regulation,
chromatin remodelling and the propagation of methylation-
free islands (2,3,45–50). Thus, a cell lacking Sp1 would be
predicted to stand little chance of survival. Surprisingly, Sp1
null ES cells could be generated without any difficulty and
these cells showed normal growth characteristics, maintained
their methylation-free islands and could differentiate in vitro to
form embryoid bodies with similar efficiencies to control ES
cells (51; U.Jägle, unpublished results). However, all Sp1 null
embryos are severely retarded in growth and die after day 10 of
development. They display a wide range of abnormalities at
Figure 3. Structural features of Sp/XKLF family members. Each coloured box
refers to the region containing a preponderance of one or several types of
amino acids. The black boxes represent the zinc fingers. Activation (A) and
repression (R) domains are indicated. Connecting lines depict similarities of
the transcription factors outside the zinc fingers. The sizes (amino acids) of the
proteins are indicated on the right and refer to the human proteins with the
exception of LKLF, AP-2rep, BKLF and IKLF, which refer to mouse proteins.
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cells, while in others all the typical hallmarks of early embryo-
genesis are present, such as the developing heart, eyes, otic
vesicles, somites, erythroid cells and extra-embryonic tissues.
Blastocyst injections with Sp1 null ES cells showed that these
cells initially contribute efficiently to chimaeric embryos, but
after day 11 of development this declines very rapidly, with no
detectable contribution to any tissue of newborn animals.
Thus, Sp1 deficiency causes a cell-autonomous defect and it
appears that Sp1 function is generally required for cellular
survival after day 10 of mouse development (51). The Sp1 null
phenotype is remarkably similar to the phenotypes described
for two proteins involved in DNA methylation: the DNA
methyltransferase enzyme, Dnmt1 (1), and the methyl-CpG-
binding protein, MeCP2 (52). Expression levels of Dnmt1
were normal in the Sp1 knockout embryos and no changes in
DNA methylation patterns could be detected. However, MeCP2
protein levels were reduced 20-fold in the absence of Sp1. Like
Sp1, MeCP2 is dispensable for growth and differentiation of ES
cells, but MeCP2-deficient cells are unable to contribute to
mouse tissues after early embryogenesis. Thus, it has been
proposed that MeCP2 is required for the maintenance of differ-
entiated cells. The phenotype of the Sp1 knockout suggests
that Sp1 has an essential role in cellular survival during mouse
development by acting as a regulator of MeCP2 expression.
Sp4: is it all between the ears?
Sp4 is highly expressed in the developing central nervous system,
but it is also abundant in epithelial tissues, developing teeth
and testes. Sp4 knockout mice are born at normal Mendelian
ratios but two-thirds of these mice die within a few days after
birth (53). Reduced body weight and a slightly stunted
appearance are features of Sp4 null mice (our own unpublished
observations). The most interesting aspect of the phenotype is
the complete absence of mating behaviour in Sp4 null males.
Since their reproductive organs are fully developed and
apparently normal, with the testes containing motile mature
sperm, the most likely cause of this behavioural abnormality is
a neurological defect. Surgical removal of the vomeronasal
organ in newborn mice results in the absence of mating behaviour
later in life and the hypothalamus is also known to play an
important role in reproductive behaviour. However, both the
vomeronasal organ and the hypothalamus have a histologically
normal appearance in Sp4 null mice (53). It remains possible
that a specific subset of cells is missing in either of these
organs. The vomeronasal organ is primarily important for the
detection of pheromones and a family of putative pheromone
receptors expressed in this organ has been described. It is con-
ceivable that the subset of neurons expressing the pheromone
receptors that elicit reproductive behaviour are missing in the
Sp4 null males, but this awaits further investigation.
EKLF: one factor to activate one gene?
Since EKLF is expressed specifically in erythroid cells it was
not surprising that EKLF null mutants die in utero due to
severe anaemia (54,55). The production of the first, nucleated
red cells in the yolk sac (primitive erythropoiesis) was not
affected but the generation of enucleated erythrocytes in the
fetal liver (definitive erythropoiesis) was severely impaired.
EKLF null mice fail to express adult-type β-like globin genes
in definitive erythroid cells, but do express all the other
erythroid-specific genes examined at normal levels, including
the embryonic β-like globins in primitive cells (54,55).
Unlike humans, mice do not possess fetal-specific β-globin
genes. Nevertheless, the switch from fetal (γ) to adult (β) gene
expression is reproduced in definitive erythropoiesis of trans-
genic mice harbouring the complete human β-globin locus
(56). This switching process was studied in EKLF knockouts,
revealing that the γ-globin genes were fully activated as
opposed to a complete failure to express the β-globin gene.
Furthermore, the kinetics of switching correlates with EKLF
levels. It is delayed in EKLF heterozygotes, but expedited by
transgenic overexpression of EKLF. This has identified EKLF
as the first factor that is directly involved in γ to β switching
(57). Since the γ genes are still silenced after the switching
period, it is unlikely that EKLF has a role to play in γ gene
silencing. Thus, EKLF is an adult-specific factor required for
activation of the β gene promoter in definitive erythropoiesis.
It is noteworthy that mutations in the EKLF-binding site of the
β promoter have been described in certain β-thalassaemia
patients (58).
Erythroid precursors are found in normal numbers in EKLF
null mutants and erythroid maturation per se is thought to
ensue normally (54,55,59). This leaves us with an uncomfortable
question: does EKLF activate only one particular gene in one
particular locus? Thiswould be a very cumbersomemechanism to
regulate gene expression. Fortunately, there exist some data
suggesting additional roles for EKLF. One piece of data
suggests that EKLF function is required for red cell stability
(60). This suggestion is underpinned by the observation that
forced expression of γ-globin or β-globin chains under the
control of EKLF-independent promoters does not alleviate the
fatal anaemia of EKLF null mutants (61; M.Wijgerde, unpublished
data).
LKLF: a survival and maturation factor?
Analysis of the LKLF knockout has revealed several interesting
aspects of its function in the development and physiology of
mice. LKLF null fetuses die in utero as a result of exsanguination
due to intra-embryonic and intra-amniotic bleeding. Impaired
fetal liver haematopoiesis has been observed (62), but the
primary cause of lethality is a defect in blood vessel mor-
phology (63). The mechanism of action of LKLF is unknown.
LKLF might be required for the survival of endothelial cells
after completion of the primitive vasculature. Alternatively,
LKLF null vessels might fail to produce growth factors that
serve as signals to attract and organise the cells required for
tunica media formation, an essential process for vessel wall
stabilisation. Expression of the prospective factors (angio-
poietins 1 and 2, TGFβ, Tie 1 and Tie 2, epidermal growth
factor and platelet-derived growth factor B) has been assessed
by in situ hybridisation and was found to be normal (63).
Therefore, the downstream effector molecules of LKLF
function in vessel wall stabilisation remain elusive.
A first glimpse of LKLF functions at later developmental
stages has been provided by the analysis of chimaeric mice
made with LKLF null ES cells. These data have demonstrated
a role for LKLF in the maintenance of mature T cells (64).
Mature T cells are present in the circulation in a resting state
and become activated if their T cell receptors bind the appro-
priate peptide antigens presented by major histocompatibility
molecules. Activated T cells start expressing a large number of
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LKLF protein levels are significantly reduced upon activation
of mature T cells. Activated T cells are more prone to undergo
apoptosis in the peripheral lymphoid organs. This is thought to
reflect a host defence mechanism against autoimmune reactions.
In chimaeric mice, LKLF null T cells are in a spontaneously
activated state, triggering their removal from the circulation
through apoptosis in the peripheral lymphoid organs. Thus,
these data demonstrate that LKLF regulates the resting state
and survival of mature T cells. The link between proliferation,
differentiation and survival of highly specialised cell types
could very well serve as a paradigm for the other Sp/XKLF
family members.
BKLF: a proliferation switch?
Only a preliminary report on the phenotype of the BKLF
knockout has appeared (65). BKLF null mice come to term and
develop normally. However, they develop a chronic myelo-
proliferative disease during adulthood. An excess of myeloid
cells is already found in utero and BKLF null myeloid cells
have an increased proliferative capacity in vitro (65). A
detailed description of the phenotype would be of interest, in
particular in relation to the activated phenotype of LKLF null
T cells. Are similar switches controlling cellular proliferation
operated by BKLF in myeloid and by LKLF in T cells? Fur-
thermore, BKLF levels are reduced in fetal livers of EKLF
knockout mice (55) and it would therefore be interesting to
know what happens to EKLF levels in BKLF null mice.
Who’s done it?
To understand regulation by Sp/XKLF family members it is of
pivotal importance to determine the binding site–transcription
factor relationships that are relevant under physiological
conditions. Knockouts may provide the first clues to answer
this question. However, these data are always indirect because
the effects on gene transcription may be due to secondary
effects of the knockout phenotype. A systematic approach to
tackle this problem for Sp/XKLF proteins has recently been
described. It is based on earlier work in which a DNA-binding
specificity mutant was used to show a direct in vivo interaction
between a DNA target site and a transcription factor in
D.melanogaster (66). This protocol was adapted to a function-
ally important GT box motif in the β-globin LCR that interacts
with Sp/XKLF factors. Sp1, Sp3, BKLF, EKLF and possibly
other Sp factors are present in erythroid cells (50,67). Which of
these factors is directly acting through the GT box motif in the
β-globin LCR? To address this issue, the GT box of the β-
globin LCR was first mutated to abolish binding of wild-type
Sp/XKLF factors. The amino acids in EKLF and Sp1 involved
in DNA recognition were changed such that the mutated zinc
finger domains would recognise the mutated element (68,69).
The capacity of the mutated Sp1 and EKLF factors to activate
β-globin gene transcription through the mutant GT box was
then assayed in transgenic mice. The analysis showed that
EKLF acts in vivo through this element, resulting in a stronger
DNase I hypersensitive site over the LCR fragment and activation
of β-globin gene transcription. No such effect was observed
with Sp1, emphasising the specific role of EKLF in this context
(67). Thus, in addition to the β-globin promoter site revealed
by the knockout (see above), EKLF has a functional target site
in the main regulatory element of the β-globin locus, the LCR.
These data do not exclude a functional role for other Sp factors
in LCR activity. It would be of particular interest to find EKLF
relatives that activate other erythroid-specific genes through
GT boxes and to extend this analysis to primitive erythroid
cells, since these are unaffected by the EKLF knockout. In this
regard, the recently reported FKLF protein is an exciting
candidate (31).
HOW TO GET SPECIFICITY?
The initial characterisation of the different Sp/XKLF family
members provides much information about the potential
functions and activities of these proteins. The most obvious
question, however, concerns the specificity of the individual
family members. That specificity exists is illustrated by the
distinct knockout phenotypes of the different family members.
The question remains: how is it obtained? Binding site prefer-
ences confer a certain level of specificity. Although all proteins
recognise very similar DNA target sites, the relative affinities
for specific sequences differ. For instance, Sp factors bind
more tightly to GC boxes than to GT boxes (70) while XKLF
bind preferentially to GT boxes (9–11,71).
Another level of specificity is obtained by the expression
patterns of individual family members. Some factors, like Sp1
and Sp3, are ubiquitously expressed, and others, like the
TIEGs, have a quite widespread distribution (Table 1). A third
group is restricted to certain cell types, for instance EKLF to
erythroid cells. However, it should be mentioned that in most
cases only the mRNA distribution has been analysed. This
does not necessarily reflect the distribution and the level of the
protein. BTEB1 mRNA is expressed ubiquitously, but the pro-
tein was found in only a few tissues (72). A careful analysis of
the expression pattern of the protein rather than the mRNAwill
yield new insights into the real distribution of the other family
members that might be helpful in understanding their function.
It is clear that in any given cell type co-expression of several
family members occurs and we have to assume that these
proteins will compete for the same binding sites. The abundance
of factors may vary among different cell types and under
certain conditions. Alterations in relative abundance have been
reported in some cases. In primary keratinocytes, Sp3 levels
exceed those of Sp1. This Sp3:Sp1 ratio becomes inverted if
the cells are allowed to differentiate (73). In NIH 3T3 cells,
GKLF mRNA is high in quiescent cells, but almost undetectable
in proliferating cells (27). TIEG1 is induced by TGFβ, EGF
and oestrogens in several cell types (24,25,74,75).
DNA-binding studies are usually performed in vitro on isolated
recognition sequences. However, promoters contain recognition
sequences for many different transcription factors and full
activation requires simultaneous binding of a whole set of tran-
scription factors that might bind cooperatively to their sites or
act synergistically by other mechanisms. So far, little is known
of how the different Sp/XKLFs proteins act on natural promoters
in combination with other transcription factors in vivo.
That different Sp/XKLF proteins might act in a highly specific
manner with other transcription factors would be expected
since the domains N-terminal of the zinc finger region have
little homology between individual family members. Evidence
for promoter specificity came from experiments with the
EKLF and Sp1 activation domains. In Gal4 fusions, the EKLF
activation domain activated the appropriate β-globin promoter
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EKLF provides crucial transactivation functions for β-globin
expression was also demonstrated in transgenic mice experi-
ments (67).
A further level of specificity could be obtained by interaction
with specific co-activators or co-repressors. In the case of
BKLF, a protein termed mCtBP2 (murine C-terminal binding
protein 2) that binds to the repression domain of BKLF and
that could act as a co-repressor has been cloned (38). EKLF
requires a SWI/SNF-related chromatin remodelling complex,
the so-called EKLF co-activator remodelling complex 1 (E-RC1),
to generate a DNase I hypersensitive, transcriptionally active
β-globin promoter on chromatin templates in vitro (77). In
addition, the co-activator complex CRSP (cofactor required for
Sp1 activation) is required for transcriptional activation by Sp1
in vitro (78). Whether CRSP is specific for Sp1 or whether it
could also cooperate with other Sp family members remains to
be established.
One could speculate that protein modifications control the
interaction with cofactors that would generate specificity. Sp1
for instance is phosphorylated (79) and glycosylated (80).
EKLF is phosphorylated at serine and threonine residues in
vivo and the minimal 40 amino acid transactivation domain
contains a casein kinase II phosphorylation site (81). Mutation of
this site abolished the activity of this domain in transactivation
assays. Furthermore, EKLF undergoes post-translational
acetylation within its inhibitory domain and co-transfection
with the acetyltransferases CBP and p300, but not P/CAF,
enhances the transactivation potential of EKLF (82). Altogether,
unravelling the molecular basis for the specificity of individual
Sp/XKLF family members represents a formidable scientific
challenge.
FUTURE DIRECTIONS
Research on Sp/XKLF proteins has made rapid advances in the
last few years, with more and more family members being
identified. Most of the knowledge is derived from biochemical
analyses, in vitro protein–DNA interaction studies and trans-
fection experiments. The knockouts published to date show
that individual family members do have specific functions in
the mouse. However, even knockout mice may not reflect the
whole truth because so little is known about the extent of over-
lapping functions. For instance, inactivation of Sp1 was
expected to have dramatic effects at the cellular level since it
was generally believed that Sp1 is the essential transcription
factor for expression of housekeeping genes. Possibly, Sp1 is
indeed engaged in the expression of these genes in vivo, but
functionally replaced by Sp3 under knockout conditions. In
addition, since deletion of the Sp1 gene leads to lethality early
in development, the role of Sp1 in fully developed tissues
remains an open question. In this regard, it is interesting to note
that mutations of Sp1-binding sites in the LDL receptor and
collagen type Iα1 genes have been associated with hyper-
cholesterolaemia and osteoporosis in humans (83–85).
Conditional disruption (86–88) of the Sp1 gene in specific
tissues at any given stage of development will be an important
step to further unravel the physiological role of Sp1 in vivo.
The identification of target genes presents another formidable
challenge. Recent advances in the detection of differentially
expressed genes and the development of DNA microchip
arrays provide very useful tools for high throughput analysis of
target genes (89). This should be of great help in understanding
the downstream effects that result in the knockout phenotypes.
To fully understand the physiological function of the Sp/
XKLF proteins, it will be equally important to understand the
mechanisms of their mode of action. Detailed characterisation
of the individual transcription factors, identification of specific
interaction partners, careful analysis of protein modifications
and the identification of signals and transduction pathways by
which these proteins are regulated will be essential for a mech-
anistic understanding of transcriptional control by this growing
family of transcription factors. With the steadily increasing
collection of knockout mice and the large arsenal of in vitro
and in vivo analysis systems available to the scientific community,
many more exciting results can be expected in the near future.
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